Clinical Trial Update: Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha

View source ↗

Summary

The clinical trial evaluating discontinuation of imatinib mesylate in patients with chronic-phase chronic myeloid leukemia previously treated with interferon-al…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Chronic Myeloid Leukemia | Status: TERMINATED